Evaluation of the MMR status in eight different tumor types from MMR gene mutation carriers showed that breast carcinoma had the lowest frequency of MMR protein inactivation and the second lowest frequency of MSI (Figure 3A). This evidence concerns the gene MRC1 and neoplasm.